Genetics of iron regulation and the possible role of iron in Parkinson's disease

被引:90
|
作者
Rhodes, Shannon L. [1 ]
Ritz, Beate [2 ]
机构
[1] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA
关键词
Parkinson's disease; Iron regulatory proteins; Genetics; Pathogenesis;
D O I
10.1016/j.nbd.2008.07.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is acknowledged as the second most common neurodegenerative disorder after Alzheimer's Disease. Older age may be the only unequivocal risk factor for PD although the male to female ratio is consistently greater than 1 in populations of European ancestry. Characteristic features of PD include dopaminergic neuron death in the substantia nigra (SN) pars compacta, accumulation of alpha-synuclein inclusions known as Lewy bodies in the SN, and brain iron accumulation beyond that observed in non-PD brains of a similar age. In this review article, we will provide an overview of human and animal studies investigating the contributions of iron in PD, a summary of human studies of iron-related genes in PD, a review of the literature on the genetics of iron metabolism, and some hypotheses on possible roles for iron in the pathogenic processes of PD including potential interactions between iron and other factors associated with Parkinson's disease. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:183 / 195
页数:13
相关论文
共 50 条
  • [21] Iron metabolism and Parkinson's disease
    Hirsch, EC
    Faucheux, BA
    MOVEMENT DISORDERS, 1998, 13 : 39 - 45
  • [22] Iron dyshomeostasis in Parkinson's disease
    Salazar, J.
    Mena, N.
    Nunez, M. T.
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2006, (71): : 205 - 213
  • [23] Iron and neuromelanin in Parkinson's disease
    Fasano, M
    Lopiano, L
    Digilio, G
    Giraudo, S
    Rizzone, M
    Torre, E
    Bergamasco, B
    5TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY, 2000, : 229 - 234
  • [24] Iron in Parkinson's disease revisited
    Galazka-Friedman, J
    Bauminger, ER
    Friedman, A
    HYPERFINE INTERACTIONS, 2002, 141 (1-4): : 267 - 271
  • [25] Glutathione, iron and Parkinson's disease
    Bharath, S
    Hsu, M
    Kaur, D
    Rajagopalan, S
    Andersen, JK
    BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) : 1037 - 1048
  • [26] Iron, cysteine and Parkinson’s disease
    Guy N. L. Jameson
    Monatshefte für Chemie - Chemical Monthly, 2011, 142 : 325 - 329
  • [27] Pumping iron in Parkinson's disease
    Bonn, D
    LANCET, 1996, 347 (9015): : 1614 - 1614
  • [28] Iron in Alzheimer's disease and Parkinson's disease
    Bush, A.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 5 - 5
  • [29] Role of dietary iron restriction in a mouse model of Parkinson's disease
    Levenson, CW
    Cutler, RG
    Ladenheim, B
    Cadet, JL
    Hare, J
    Mattson, MP
    EXPERIMENTAL NEUROLOGY, 2004, 190 (02) : 506 - 514
  • [30] Application of synchrotron radiation in neuromicrobiology: role of iron in Parkinson's disease
    Yoshida, S
    Ide-Ektessabi, A
    Fujisawa, S
    STRUCTURAL CHEMISTRY, 2003, 14 (01) : 85 - 95